With DCGI Nod in hand, Roche launches Breast Cancer Drug Atezolizumab in India Medical Dialogues Bureau9 April 2020 7:00 AM GMTNew Delhi: Drug firm Roche India on Wednesday said it has launched immunotherapy drug Atezolizumab for the treatment of metastatic triple-negative brea...
Roche Venclexta/Venclyxto combination shows promising results in phase III VIALE-A study in Leukemia patients Medical Dialogues Bureau29 March 2020 6:45 AM GMTVenclexta/Venclyxto is being developed by AbbVie and Roche.
Genentech,BARDA gets USFDA nod for Actemra Clinical Trial in COVID-19 patients Medical Dialogues Bureau28 March 2020 4:45 AM GMTUS: Genentech, a member of the Roche Group has announced the U.S. Food & Drug Administration (FDA) has approved a randomized, double-blind,...
Roche Diagnostics India first private firm to get COVID-19 test approval Medical Dialogues Bureau20 March 2020 4:30 AM GMTNew Delhi: Roche Diagnostics India has received the license from the country's drug regulator DCGI for its ''Cobas SARS CoV-2'' diagnostic test kit, ma...
Roche begins Phase III clinical trial of Actemra in hospitalised patients with severe COVID-19 pneumonia Medical Dialogues Bureau20 March 2020 4:30 AM GMTBasel: Roche has announced that it is working with the Food & Drug Administration (FDA) to initiate a randomised, double-blind, placebo-controlled ...
Roche gets USFDA Emergency Use Authorization for its Cobas SARS-CoV-2 Test Medical Dialogues Bureau15 March 2020 7:19 AM GMTBasel: Roche has announced that the U.S. Food and Drug Administration (FDA) has issued an Emergency Use Authorization (EUA) for the cobas® SARS-CoV-2 T...
Roche gets USFDA nod for CINtec PLUS Cytology test for cervical cancer Medical Dialogues Bureau12 March 2020 6:42 AM GMTCINtec PLUS Cytology provides definitive information about which HPV-positive women may benefit most from immediate referral to colposcopy versus...
Roche secures CE Mark for Accu-Chek SugarView app for diabetes management Farhat Nasim10 Dec 2019 7:37 AM GMTNow officially classified as in-vitro diagnostics (IVD) software, the app will be made widely accessible by Roche first for certain smartphone models v...
Drugmakers including Novartis, Roche slash prices by 61pc in China to get on reimbursement list Medical Dialogues Bureau29 Nov 2019 3:45 AM GMTSeventy new drugs such as Roche's breast cancer treatment Pertuzumab, sold under the trade name Perjeta, Novartis's dermatitis treatment Omalizumab, br...
Roche anticipates USFDA nod for SMA drug Risdiplam by early 2020 Medical Dialogues Bureau26 Nov 2019 3:58 AM GMTRoche, whose drug Risdiplam is seen as a rival for Biogen's Spinraza and Novartis's Zolgensma gene therapy, said the FDA is due to decide by May 24....
Tecentriq-Avastin cocktail helps liver cancer patients live longer: Roche Medical Dialogues Bureau25 Nov 2019 3:30 AM GMTMedian overall survival for patients with unresectable hepatocellular carcinoma (HCC), or that which cannot be surgically removed, getting Tecentriq an...
FIRST: Roche wins DCGI nod for Atezolizumab to treat small-cell lung cancer Medical Dialogues Bureau22 Nov 2019 6:55 AM GMT'Atezolizumab is the first cancer immunotherapy to receive approval from DCGI in India for the first-line treatment of extensive-stage small-cell lung ...
